RA Miller

950 total citations
12 papers, 792 citations indexed

About

RA Miller is a scholar working on Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, RA Miller has authored 12 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 8 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Genetics. Recurrent topics in RA Miller's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Lymphoma Diagnosis and Treatment (8 papers) and Chronic Lymphocytic Leukemia Research (4 papers). RA Miller is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Lymphoma Diagnosis and Treatment (8 papers) and Chronic Lymphocytic Leukemia Research (4 papers). RA Miller collaborates with scholars based in United States and France. RA Miller's co-authors include Ronald Levy, DG Maloney, K Thielemans, TC Meeker, James N. Lowder, Sergiu Hart, Shoshana Levy, RA Warnke, SJ Horning and Teresa Y. Basham and has published in prestigious journals such as Blood and Thrombosis and Haemostasis.

In The Last Decade

RA Miller

11 papers receiving 737 citations

Peers

RA Miller

RNMI

IMMUN

PFM

GENET

ONCOL

JM Pesando United States

RW Schroff United States

Carol B. Kobrin United States

Thelma M. Watson United States

Lee K. Sun United States

Sigrid Klein Germany

CJ Meijer Netherlands

Hirofumi Koshiba Japan

Wolfgang Haedicke Germany

Volker Diehl Germany

JM Pesando United States

RA Miller

469 ×1.0

RNMI

454 ×1.3

IMMUN

305 ×0.9

PFM

284 ×1.2

GENET

207 ×0.9

ONCOL

Citations per year, relative to RA Miller RA Miller (= 1×) peers JM Pesando

Countries citing papers authored by RA Miller

Since Specialization

Citations

This map shows the geographic impact of RA Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RA Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RA Miller more than expected).

Fields of papers citing papers by RA Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by RA Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RA Miller. The network helps show where RA Miller may publish in the future.

Co-authorship network of co-authors of RA Miller

This figure shows the co-authorship network connecting the top 25 collaborators of RA Miller. A scholar is included among the top collaborators of RA Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with RA Miller. RA Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Maloney, DG, et al.. (1992). Monoclonal anti-idiotype antibody therapy of B-cell lymphoma: the addition of a short course of chemotherapy does not interfere with the antitumor effect nor prevent the emergence of idiotype-negative variant cells. Blood. 80(6). 1502–1510. 6 indexed citations

2.

Maloney, DG, et al.. (1992). Monoclonal anti-idiotype antibody therapy of B-cell lymphoma: the addition of a short course of chemotherapy does not interfere with the antitumor effect nor prevent the emergence of idiotype-negative variant cells. Blood. 80(6). 1502–1510. 63 indexed citations

3.

Dighiero, G, et al.. (1991). Autoantibody activity of immunoglobulins isolated from B-cell follicular lymphomas. Blood. 78(3). 581–585. 3 indexed citations

4.

Hart, Sergiu, et al.. (1991). Ig VH gene expression among human follicular lymphomas. Blood. 78(6). 1561–1568. 85 indexed citations

5.

Hart, Sergiu, et al.. (1991). Ig VH gene expression among human follicular lymphomas. Blood. 78(6). 1561–1568. 5 indexed citations

6.

Dighiero, Guillaume, Sergiu Hart, Apiradee Lim, et al.. (1991). Autoantibody activity of immunoglobulins isolated from B-cell follicular lymphomas. Blood. 78(3). 581–585. 59 indexed citations

7.

Miller, RA, SJ Horning, Teresa Y. Basham, et al.. (1989). Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon. Blood. 73(3). 651–661. 6 indexed citations

8.

Miller, RA, SJ Horning, Teresa Y. Basham, et al.. (1989). Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon. Blood. 73(3). 651–661. 135 indexed citations

9.

Miller, RA, et al.. (1987). In vitro tests that predict tumor-associated idiotype levels in the serum of patients with B cell lymphomas and leukemias. Blood. 69(4). 1249–1254. 4 indexed citations

10.

Meeker, TC, James N. Lowder, DG Maloney, et al.. (1985). A clinical trial of anti-idiotype therapy for B cell malignancy. Blood. 65(6). 1349–1363. 357 indexed citations

11.

Wood, GS, et al.. (1982). Subtypes of cutaneous T-cell lymphoma defined by expression of leu-1 and Ia. Blood. 59(5). 876–882. 66 indexed citations

12.

Pool, Judith G., Rosemary Biggs, & RA Miller. (1976). The Estimation of the Number of Binding Sites for Antibody on Antigen Molecules with Reference to Factor VIII and its Antibody. Thrombosis and Haemostasis. 35(2). 274–288. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact